How Fast Does Fertility Return After Cabergoline Treatment?
At a Glance
Cabergoline can restore ovulation within weeks to months, so pregnancy may occur before the first period returns. Early accidental exposure has not been linked to higher risks of birth defects or miscarriage, but whether to continue the medicine depends on the tumor’s size and location.
In this answer
3 sections
Fertility can return very rapidly after starting cabergoline for prolactinoma-related hyperprolactinemia, often within the first few weeks to months of treatment [1] [2]. Because you may ovulate before you even get your first period, it is important to start using contraception immediately if you do not want to become pregnant [3] [4]. If you are trying to conceive and become pregnant while taking cabergoline, the next step depends on the size and location of your tumor. For most people with small tumors, guidelines recommend stopping the medication once pregnancy is confirmed, but you should contact your endocrinologist promptly for individualized instructions and follow your prearranged plan rather than stopping it on your own [5] [6] [7]. Reassuringly, observational studies show that inadvertent exposure to cabergoline during the early weeks of pregnancy has not been linked to an increased risk of birth defects or miscarriages [8] [5] [9].
Note: This page focuses on hyperprolactinemia caused by a prolactinoma (a benign pituitary tumor). If your high prolactin is caused by another condition, such as hypothyroidism, kidney disease, or a medication, your treatment and pregnancy management plan will be different.
How Quickly Does Fertility Return?
When you take a dopamine agonist (a medication that lowers prolactin levels, such as cabergoline), your hormone levels often normalize very quickly. Many women who have stopped getting their periods see them return within the first three months of treatment [1] [2].
However, ovulation—the release of an egg—happens roughly two weeks before a period starts. This means you could get pregnant before having a single period after starting treatment. Because of this, it is crucial to use a reliable form of birth control from the day you start cabergoline if you are not actively trying to conceive [3] [4].
Keep in mind that while prolactin levels may fall rapidly, pregnancy is not guaranteed. If your periods do not return after your prolactin normalizes, or if you do not conceive after several months of normal cycles, your doctor may evaluate you for other fertility factors.
What to Do When You Get Pregnant
Ideally, before you try to conceive, you should have a “pre-pregnancy plan” with your endocrinologist. This plan will depend on the type of tumor you have:
- Microprolactinomas: Tumors smaller than 10 millimeters (mm).
- Macroprolactinomas: Tumors 10 mm or larger. Some of these may press on nearby structures in the brain, such as the optic nerves that control your vision.
If you suspect you are pregnant, take a pregnancy test as soon as possible. If it is positive, contact your endocrinologist and obstetrician promptly and follow your prearranged plan.
For most patients—specifically those with microprolactinomas or non-compressive macroprolactinomas—doctors generally stop cabergoline once pregnancy is confirmed [5] [6] [7]. However, if you have a macroprolactinoma that is near your optic nerves or has a history of growing, your doctor may advise you to continue taking the medication to keep the tumor under control [10] [3]. Never stop a medication that your specialist has specifically instructed you to continue.
Many women worry about the medication they took before they knew they were pregnant. Large observational studies offer reassuring evidence: inadvertent exposure to cabergoline during the first few weeks of pregnancy does not appear to increase the risk of miscarriage, premature delivery, or birth defects above the normal background rate [8] [5] [9].
Monitoring Your Health During Pregnancy
During a healthy pregnancy, prolactin levels naturally rise to very high levels to prepare your body for producing breast milk [3] [11]. Because of this normal increase, blood tests measuring prolactin are not useful for tracking a prolactinoma while you are pregnant.
Instead, your monitoring schedule will be based on your tumor’s size and location [12] [7]. If you have a microprolactinoma, you may only need regular clinical check-ins to discuss symptoms. If you have a macroprolactinoma, your doctor may schedule regular endocrinology appointments and formal vision tests throughout your pregnancy.
If a tumor grows during pregnancy, it can press on nearby structures in the brain, such as the optic chiasm (where the optic nerves cross). Do not wait for your next routine appointment if you experience:
- Severe, sudden, or persistent headaches
- Any new changes in your vision, such as blurriness or loss of your peripheral (side) vision
- Other acute neurological symptoms, like confusion or vomiting
If you develop these symptoms, contact your care team immediately or seek emergency care. Your doctor may recommend an MRI to check if the tumor has enlarged [12] [7]. MRIs during pregnancy are typically done without contrast dye, as contrast is avoided unless absolutely necessary for diagnosis.
If significant tumor growth is detected, your care team may restart you on a dopamine agonist (like cabergoline or bromocriptine) under specialist supervision to help control the tumor [13] [5] [3]. In rare cases where medication is not effective and your vision is threatened, surgery may be considered.
Common questions in this guide
How soon can I become fertile after starting cabergoline?
Do I need birth control when I start cabergoline?
Is it dangerous if I took cabergoline before realizing I was pregnant?
Should I stop cabergoline after a positive pregnancy test?
How will my prolactinoma be monitored during pregnancy?
Which pregnancy symptoms need urgent attention?
Related questions
Show more
Get notified when new evidence is published on acquired hyperprolactinemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (13)
- 1
Study of Clinical Profile and Early Response to Dopamine Agonist Therapy in Patients of Hyperprolactinemia: Experience at a Tertiary Care Centre of Nepal.
Nepal R, Bajracharya MR, Karki BB, et al.
Indian journal of endocrinology and metabolism 2025; (29(6)):667-673 doi:10.4103/ijem.ijem_252_25.
PMID: 41497301 - 2
Clinical profile and early therapeutic response to cabergoline of patients with hyperprolactinemia in a Cameroonian population.
Etoga MCE, Sobngwi E, Ngoune P, et al.
The Pan African medical journal 2020; (35()):2 doi:10.11604/pamj.2020.35.2.12883.
PMID: 32117518 - 3
Approach to the pregnant patient with prolactinoma.
Karaca Z, Kelestimur F
The Journal of clinical endocrinology and metabolism 2026; doi:10.1210/clinem/dgag408.
PMID: 42828437 - 4
Approach to the Patient With Prolactinoma.
Auriemma RS, Pirchio R, Pivonello C, et al.
The Journal of clinical endocrinology and metabolism 2023; (108(9)):2400-2423 doi:10.1210/clinem/dgad174.
PMID: 36974474 - 5
Prolactinoma and pregnancy: From the wish of conception to lactation.
Maiter D
Annales d'endocrinologie 2016; (77(2)):128-34.
PMID: 27130071 - 6
Prolactinomas in pregnancy: considerations before conception and during pregnancy.
Glezer A, Bronstein MD
Pituitary 2020; (23(1)):65-69 doi:10.1007/s11102-019-01010-5.
PMID: 31792668 - 7
Prolactinomas: how to handle prior to and during pregnancy?
Glezer A, Bronstein MD
Minerva endocrinologica 2018; (43(4)):423-429 doi:10.23736/S0391-1977.17.02792-4.
PMID: 29265784 - 8
Cabergoline Use and Pregnancy Outcomes: A Systematic Review.
Otis AS, Brochet MS, Tremblay Z, et al.
Birth defects research 2025; (117(3)):e2464 doi:10.1002/bdr2.2464.
PMID: 40116053 - 9
An observational study of pregnancy and post-partum outcomes in women with prolactinoma treated with dopamine agonists.
O'Sullivan SM, Farrant MT, Ogilvie CM, et al.
The Australian & New Zealand journal of obstetrics & gynaecology 2020; (60(3)):405-411 doi:10.1111/ajo.13070.
PMID: 31583693 - 10
Managing Prolactinomas during Pregnancy.
Almalki MH, Alzahrani S, Alshahrani F, et al.
Frontiers in endocrinology 2015; (6()):85 doi:10.3389/fendo.2015.00085.
PMID: 26074878 - 11
Prolactinomas in women of reproductive age: a proposed reproductive-intent-based framework for diagnosis and management.
Sun R, Xu X, Wei S
Frontiers in endocrinology 2026; (17()):1946204 doi:10.3389/fendo.2026.1946204.
PMID: 42840608 - 12
Endocrinology in pregnancy: management of the pregnant patient with a prolactinoma.
Molitch ME
European journal of endocrinology 2015; (172(5)):R205-13 doi:10.1530/EJE-14-0848.
PMID: 25805896 - 13
Apoplexy of microprolactinomas during pregnancy: report of five cases and review of the literature.
Kuhn E, Weinreich AA, Biermasz NR, et al.
European journal of endocrinology 2021; (185(1)):99-108.
PMID: 33914699
This page is for informational purposes only and does not constitute medical advice about cabergoline, fertility, or pregnancy. Your endocrinologist and obstetrician should guide medication changes and monitoring for your tumor.